After getting its drug pulled off the market for a few months, the relaunch of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) Iclusig is going about as good as could be expected. $8.58, while the day range of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock is $8.26 – $8.75. The stock showed a positive weekly performance of -0.58%.
John C. Martin, the chief executive officer of Gilead Sciences Inc. (GILD), has become a billionaire on the prospects of a powerful new hepatitis C drug that’s attracting scrutiny from payers and activists over its $1,000 per pill price tag. Gilead Sciences, Inc. (NASDAQ:GILD) stock opened at $82.79 in last session, and closed at $81.45 by losing -1.62%. The 52 week range of $42.38 – 84.88. Company’s market capitalization is $124.93B.
MannKind Corporation (NASDAQ:MNKD) on Feb. 18 reported financial results for the fourth quarter and full year ended December 31, 2013. The net loss applicable to common stockholders for fiscal year 2013 was $(191.5) million, or $(0.64) per share based on 299.6 million weighted average shares outstanding, compared with a net loss applicable to common stockholders of $(169.4) million, or $(0.94) per share based on 180.9 million weighted average shares outstanding for fiscal year 2012. MannKind Corporation (NASDAQ:MNKD) stock decreased -0.97% and finished the last session at $6.13. The EPS of the stock remained -0.59. Company’s market capitalization is $2.07B.
Shares of Dendreon Corp. (NASDAQ:DNDN) saw unusually large options trading activity on Monday. Stock investors purchased 6,345 put options on the stock, American Banking and Market News reports. This represents an increase of approximately 379% compared to the average daily volume of 1,326 put options. Dendreon Corporation (NASDAQ:DNDN) stock opened the session at $3.11, and closed the session at $3.31. The 52 week range of the Dendreon Corporation (NASDAQ:DNDN) stock remained $2.23 – 6.20 and the day range was $3.11 – 3.46.
Leave a Reply